$PCTY
Paylocity Holding Corp Stock $pcty

$pcty Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000159169823000238 Filed on November 03, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$326.4M	$317.6M
YoY Change	19.54%	25.39%
Cost Of Revenue	$107.4M	$101.5M
YoY Change	19.23%	20.02%
Gross Profit	$219.0M	$216.1M
YoY Change	19.7%	28.08%
Gross Profit Margin	67.09%	68.05%
Selling, General & Admin	$123.1M	$130.3M
YoY Change	-0.47%	7.21%
% of Gross Profit	56.23%	60.3%
Research & Development	$46.14M	$44.61M
YoY Change	12.45%	11.25%
% of Gross Profit	21.07%	20.64%
Depreciation & Amortization	$5.179M	$17.12M
YoY Change	13.1%	20.0%
% of Gross Profit	2.37%	7.92%
Operating Expenses	$169.3M	$174.9M
YoY Change	2.75%	8.22%
Operating Profit	$49.71M	$41.19M
YoY Change	172.99%	481.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$3.800M	$3.225M
YoY Change	-76100.0%	-2078.53%
Pretax Income	$53.51M	$44.41M
YoY Change	193.94%	541.26%
Income Tax	$15.39M	$9.897M
% Of Pretax Income	28.76%	22.28%
Net Earnings	$38.12M	$34.52M
YoY Change	144.33%	13.72%
Net Earnings / Revenue	11.68%	10.87%
Basic Earnings Per Share	$0.68	$0.62
Diluted Earnings Per Share	$0.67	$0.61
COMMON SHARES
Basic Shares Outstanding	56.18M shares	55.92M shares
Diluted Shares Outstanding	56.86M shares	56.88M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$366.9M	$305.0M
YoY Change	205.62%	365.76%
Cash & Equivalents	$366.9M	$305.0M
Short-Term Investments
Other Short-Term Assets	$3.320B	$2.565B
YoY Change	7.25%	10.17%
Inventory
Prepaid Expenses
Receivables	$32.48M	$30.11M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.807B	$2.983B
YoY Change	15.04%	20.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$63.15M	$63.34M
YoY Change	6.12%	3.93%
Goodwill	$109.6M	$102.1M
YoY Change	7.35%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$22.21M	$22.30M
YoY Change	-53.0%	-56.21%
Total Long-Term Assets	$686.0M	$663.9M
YoY Change	9.11%	7.86%
TOTAL ASSETS
Total Short-Term Assets	$3.807B	$2.983B
Total Long-Term Assets	$686.0M	$663.9M
Total Assets	$4.493B	$3.647B
YoY Change	14.09%	17.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.973M	$8.749M
YoY Change	4.76%	40.32%
Accrued Expenses	$147.1M	$131.7M
YoY Change	27.05%	24.35%
Deferred Revenue	$30.31M	$26.14M
YoY Change	28.75%	55.51%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.423B	$2.672B
YoY Change	7.33%	10.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.177M	$3.584M
YoY Change	25.32%	4.58%
Total Long-Term Liabilities	$4.177M	$3.584M
YoY Change	25.32%	4.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.423B	$2.672B
Total Long-Term Liabilities	$4.177M	$3.584M
Total Liabilities	$3.506B	$2.754B
YoY Change	7.54%	10.86%
SHAREHOLDERS EQUITY
Retained Earnings	$539.3M	$501.2M
YoY Change	45.05%	40.7%
Common Stock	$56.00K	$56.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$986.8M	$892.6M
YoY Change
Total Liabilities & Shareholders Equity	$4.493B	$3.647B
YoY Change	14.09%	17.82%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$38.12M	$34.52M
YoY Change	144.33%	13.72%
Depreciation, Depletion And Amortization	$5.179M	$17.12M
YoY Change	13.1%	20.0%
Cash From Operating Activities	$75.11M	$62.14M
YoY Change	20.43%	279.22%
INVESTING ACTIVITIES
Capital Expenditures	$18.03M	$3.454M
YoY Change	-238.62%	0.2%
Acquisitions
YoY Change
Other Investing Activities	-$34.76M	$406.0K
YoY Change	17.04%	-100.53%
Cash From Investing Activities	-$52.79M	-$9.404M
YoY Change	23.61%	-89.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	752.3M	-$122.4M
YoY Change	-2.22%	-93.06%
NET CHANGE
Cash From Operating Activities	75.11M	$62.14M
Cash From Investing Activities	-52.79M	-$9.404M
Cash From Financing Activities	752.3M	-$122.4M
Net Change In Cash	774.6M	-$69.66M
YoY Change	-1.83%	-96.21%
FREE CASH FLOW
Cash From Operating Activities	$75.11M	$62.14M
Capital Expenditures	$18.03M	$3.454M
Free Cash Flow	$57.09M	$58.69M
YoY Change	-24.26%	353.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	7874000	usd
CY2023Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	25901000	usd
CY2022Q3	us-gaap	Revenues Revenues	253280000	usd
CY2023Q3	us-gaap	Revenues Revenues	317586000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	84543000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	101467000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	168737000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	216119000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	71063000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	80403000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40093000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44605000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50492000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49922000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	161648000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	174930000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	7089000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	41189000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-163000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3225000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6926000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44414000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23426000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9897000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	30352000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	34517000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2372000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	120000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27980000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34637000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55453000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56037000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56664000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56881000	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	613463000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43471000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2832000	usd
CY2022Q3	pcty	Stock Issued During Period Value Restricted Stock Units Vesting StockIssuedDuringPeriodValueRestrictedStockUnitsVesting	0	usd
CY2022Q3	pcty	Net Settlement For Taxes Andor Exercise Price Related To Equity Awards NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards	76900000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2372000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	610846000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	842863000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43964000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	223000	usd
CY2023Q3	pcty	Net Settlement For Taxes Andor Exercise Price Related To Equity Awards NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards	29048000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	120000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	34517000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	892639000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	34517000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	39005000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17121000	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5391000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	181000	usd
CY2023Q3	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1392000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	94000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	65000	usd
CY2022Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	125000	usd
CY2023Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	124000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6020000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4801000	usd
CY2022Q3	pcty	Increase Decrease In Capitalized Contract Cost IncreaseDecreaseInCapitalizedContractCost	19328000	usd
CY2023Q3	pcty	Increase Decrease In Capitalized Contract Cost IncreaseDecreaseInCapitalizedContractCost	14985000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-614000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1669000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1805000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1569000	usd
CY2022Q3	pcty	Increase Decrease In Accrued Liabilities And Other Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities	-17734000	usd
CY2023Q3	pcty	Increase Decrease In Accrued Liabilities And Other Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities	-12984000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16387000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	62142000	usd
CY2022Q3	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	118926000	usd
CY2023Q3	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	92567000	usd
CY2022Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	42850000	usd
CY2023Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	101216000	usd
CY2022Q3	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9953000	usd
CY2023Q3	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	14193000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3447000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3454000	usd
CY2022Q3	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023Q3	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	406000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-89476000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9404000	usd
CY2022Q3	pcty	Increase Decrease In Client Funds Obligation IncreaseDecreaseInClientFundsObligation	1688339000	usd
CY2023Q3	pcty	Increase Decrease In Client Funds Obligation IncreaseDecreaseInClientFundsObligation	93566000	usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28825000	usd
CY2022Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	855000	usd
CY2023Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-122402000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-69664000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2351648000	usd
CY2023Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1803000	usd
CY2022Q3	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	117000	usd
CY2023Q3	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	62000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	124000	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	19000	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6207000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65484000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305031000	usd
CY2022Q3	pcty	Funds Held For Clients Cash And Cash Equivalents At Carrying Value FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue	1891615000	usd
CY2023Q3	pcty	Funds Held For Clients Cash And Cash Equivalents At Carrying Value FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue	2046617000	usd
CY2022Q3	pcty	Cash Cash Equivalents And Funds Held For Clients Cash And Cash Equivalent CashCashEquivalentsAndFundsHeldForClientsCashAndCashEquivalent	1957099000	usd
CY2023Q3	pcty	Cash Cash Equivalents And Funds Held For Clients Cash And Cash Equivalent CashCashEquivalentsAndFundsHeldForClientsCashAndCashEquivalent	2351648000	usd
CY2023Q3	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) Organization and Description of Business</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Paylocity Holding Corporation (the “Company”) is a cloud-based provider of human capital management and payroll software solutions that deliver a comprehensive platform for the modern workforce. Services are provided in a Software-as-a-Service (“SaaS”) delivery model. The Company’s comprehensive product suite delivers a unified platform that helps businesses attract and retain talent, build culture and connection with their employees, and streamline and automate HR and payroll processes.
CY2023Q3	pcty	Period Of Term Arrangement PeriodOfTermArrangement	P2Y
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	245406000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	291685000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12233000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	22617000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8232000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10644000	usd
CY2022Q3	pcty	Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability	6270000	usd
CY2023Q3	pcty	Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability	9121000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14195000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24140000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P7Y
CY2022Q3	pcty	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	35774000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-15730000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	308612000	usd
CY2023Q3	pcty	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	36215000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-20320000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	388226000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	72578000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P24M
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1620000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	181000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	49000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1752000	usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	248738000	usd
CY2023Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	162611000	usd
CY2023Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	86127000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	141955000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77886000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	64069000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	4454000	usd
CY2023Q3	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	68569000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	68569000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34042000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36578000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34527000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31991000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2771000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2536000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7407000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8888000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7269000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4893000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3029000	usd
CY2023Q3	pcty	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	505000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31991000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85019000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	71528000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7800000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8423000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	24539000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26141000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25929000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25601000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	143287000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	131693000	usd
CY2023Q2	pcty	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	288767000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288767000	usd
CY2023Q2	pcty	Funds Held For Clients Cash And Cash Equivalents Amortized Cost FundsHeldForClientsCashAndCashEquivalentsAmortizedCost	2132545000	usd
CY2023Q2	pcty	Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q2	pcty	Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q2	pcty	Funds Held For Clients Cash And Cash Equivalents At Carrying Value FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue	2132545000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	494741000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	45000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5916000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	488870000	usd
CY2023Q2	pcty	Investments Amortized Cost InvestmentsAmortizedCost	2916053000	usd
CY2023Q2	pcty	Investments Accumulated Gross Unrealized Gain Before Tax InvestmentsAccumulatedGrossUnrealizedGainBeforeTax	45000	usd
CY2023Q2	pcty	Investments Accumulated Gross Unrealized Loss Before Tax InvestmentsAccumulatedGrossUnrealizedLossBeforeTax	5916000	usd
CY2023Q2	us-gaap	Investments Investments	2910182000	usd
CY2023Q3	pcty	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	305031000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305031000	usd
CY2023Q3	pcty	Funds Held For Clients Cash And Cash Equivalents Amortized Cost FundsHeldForClientsCashAndCashEquivalentsAmortizedCost	2046617000	usd
CY2023Q3	pcty	Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q3	pcty	Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q3	pcty	Funds Held For Clients Cash And Cash Equivalents At Carrying Value FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue	2046617000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	487484000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5770000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	481736000	usd
CY2023Q3	pcty	Investments Amortized Cost InvestmentsAmortizedCost	2839132000	usd
CY2023Q3	pcty	Investments Accumulated Gross Unrealized Gain Before Tax InvestmentsAccumulatedGrossUnrealizedGainBeforeTax	22000	usd
CY2023Q3	pcty	Investments Accumulated Gross Unrealized Loss Before Tax InvestmentsAccumulatedGrossUnrealizedLossBeforeTax	5770000	usd
CY2023Q3	us-gaap	Investments Investments	2833384000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288767000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305031000	usd
CY2023Q2	us-gaap	Funds Held For Clients FundsHeldForClients	2621415000	usd
CY2023Q3	us-gaap	Funds Held For Clients FundsHeldForClients	2528353000	usd
CY2023Q2	us-gaap	Investments Investments	2910182000	usd
CY2023Q3	us-gaap	Investments Investments	2833384000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2305000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	344035000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3611000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	104818000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	5916000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	448853000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2141000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	319949000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3629000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	121240000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	5770000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	441189000	usd
CY2023Q3	pcty	Credit Impairment Loss CreditImpairmentLoss	0	usd
CY2022Q3	pcty	Credit Impairment Loss CreditImpairmentLoss	0	usd
CY2022Q3	pcty	Credit Impairment Loss CreditImpairmentLoss	0	usd
CY2023Q3	pcty	Credit Impairment Loss CreditImpairmentLoss	0	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis	207177000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	205662000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	171288000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	168364000	usd
CY2023Q3	pcty	Available For Sale Securities Debt Maturities Two Years To Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesTwoYearsToThreeYearsAmortizedCost	88935000	usd
CY2023Q3	pcty	Available For Sale Securities Debt Maturities Two Years To Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesTwoYearsToThreeYearsFairValue	87761000	usd
CY2023Q3	pcty	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year Three Through Five DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearThreeThroughFive	20084000	usd
CY2023Q3	pcty	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year Three Through Five DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearThreeThroughFive	19949000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	487484000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	481736000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305031000	usd
CY2023Q3	pcty	Funds Held For Clients Cash And Cash Equivalents At Carrying Value FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue	2046617000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	481736000	usd
CY2023Q3	us-gaap	Investments Investments	2833384000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39813000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39005000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2942000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4049000	usd
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	647000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82000	shares
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-3.382
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.223
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30352000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	34517000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55453000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56037000	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1211000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	844000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56664000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56881000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001591698-23-000238-index-headers.html	Edgar Link	pending
0001591698-23-000238-index.html	Edgar Link	pending
0001591698-23-000238.txt	Edgar Link	pending
0001591698-23-000238-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcty-20230930.htm	Edgar Link	pending
pcty-20230930.xsd	Edgar Link	pending
pcty-20230930x10qex311.htm	Edgar Link	pending
pcty-20230930x10qex312.htm	Edgar Link	pending
pcty-20230930x10qex313.htm	Edgar Link	pending
pcty-20230930x10qex321.htm	Edgar Link	pending
pcty-20230930x10qex322.htm	Edgar Link	pending
pcty-20230930x10qex323.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
pcty-20230930_def.xml	Edgar Link	unprocessable
pcty-20230930_pre.xml	Edgar Link	unprocessable
pcty-20230930_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pcty-20230930_lab.xml	Edgar Link	unprocessable
pcty-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCTY
Paylocity Holding Corp Stock $pcty

2023 Q4 Form 10-Q Financial Statement

#000159169823000238 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCTY Paylocity Holding Corp Stock $pcty

2023 Q4 Form 10-Q Financial Statement

#000159169823000238 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCTY
Paylocity Holding Corp Stock $pcty